 IRVINE, Calif., March 03, 2021 GLOBE NEWSWIRE -- Oncocyte Corporation NYSE American: OCX, a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, today announced that it will release its financial and operating results for the fourth quarter and year ended December 31, 2020, on Tuesday, March 16, 2021, after the close of the U.S. financial markets. The Company will host a conference call on Tuesday, March 16, 2021, at 4:30 pm ET 1:30 pm PT to discuss the results along with recent corporate developments. 